Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cantabio Pharmaceuticals, Inc. (CTBO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.01000.0000 (0.00%)
At close: 02:08PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.0100
Open1.0100
BidN/A x N/A
AskN/A x N/A
Day's Range1.0100 - 1.0100
52 Week Range1.0100 - 1.0100
Volume24
Avg. Volume0
Market Cap563,600
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-130.8330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CTBO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CANTABIO PHARMACEUTICALS INC
    Technical Assessment: Neutral in the Intermediate-TermInterest rates across the entire curve went somewhat parabolic in August. The U.S. Dollar Index continued its very steep ascent. The Federal Reserve is maintaining its hawkish stance based on its latest fed funds targets. As well, the Fed "finally" is getting its quantitative tightening (QT) in gear, which pulls liquidity out of the marketplace. Oh, and stock investors have been losing massive amounts of money. One might believe the economy is falling off a cliff. At least gasoline prices have crashed.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement